Welcure Drugs & Pharmaceuticals Ltd
company logo

Welcure Drugs & Pharmaceuticals Ltd

WELCUREDRUGS Share Price

BSE:524661

0.31

0 (0%)

As on April 20, 2026 at 04:00 PM
Loading chart...

Performance

Loading performance...

0.31

0.32

6022501

0.19

1

Fundamentals

38.31Cr

1.07

0.29

1.19

0.29

0%

1.09

About

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain. The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL). The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations. It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen. It manufactures over a hundred varieties of tablets, capsules and dry syrups, sulpha drugs, vitamins, analgesics, etc. Its subsidiary, AKL, manufactures 6-APA, a key drug intermediate in the manufacture of semi-synthetic penicillin. The company has decided to set up new sections of paediatrics and veterinary drugs and to diversify into ointments and liquid syrups. The new products of the company WELSTAP , X- CLOX , ETHAMBUTOL, RIFA- Z , CETIRIZIN , NORTIN have been well accepted in the market. The Company has entered into a collaboration agreement with a russian company to act as their sole selling agent for a unique medicine Stevioside, an alternate to sugar, Saccharin and Aspartame. The Company has added a new liquid oral plant in Bhiwadi, Rajasthan. It has obtained ISO 9002 certification with double accredition from ABS Quality Evaluation Inc Texas and by Registrar of Accredition Board of USA. Welcure has also entered into an agreement with Bihar Drugs and Chemicals Ltd, a government of Bihar undertaking, for manufacturing their products in its factory on loan basis. During the year 2000-01 the company had launched some products like CEZEN,DIMCIN PLUS,OXIN,SPASWIN etc.The company has entered into technical collaboration agreement with Advanced Medical Care Inc New Jersey USA for setting up of joint venture facilities in the existing plant of the company. During the year 2001-02, the company had launched products like B-ZEX, DMART PLUS, DRALPIN, DUKESPAS, DUBAMOL, HISTACURE, KUFFWEL, KINGSPAS, LANAX, PETRIMAX, PEEROSCAM, RENACT, SARVO, WELCEE, WELGESIC, WELIC, WELOXY, WELRELEEF, X-DRYL. It changed its marketing policy from 'Sales through Wholesale Distributors' to ' Sales at Doorstep' by reaching every corner of the country and by putting dual force on Sales-through sales personnel on one hand and through stockists and distributors on the other hand. The Company is carrying on the business of manufacturers, designers, repairers, installers, merchants, importers, exporters, agent for sale and distributors of and dealers in water processing equipment and purifiers, and water softeners of every description. Apart from these, it deals in real estate and engaged in creating exceptional living and working spaces for the new Indian global professionals.

1996

NameDesignation
Chintan DidawalaExecutive Director & MD
Yogeshkumar PrajapatiIndependent Non Exe. Director
Bhumika PradhanIndependent Non Exe. Director
Ravi ThakorIndependent Non Exe. Director
Palak JainCompany Sec. & Compli. Officer

Welcure Drugs & Pharmaceuticals Ltd FAQs

How do I Buy Welcure Drugs & Pharmaceuticals Ltd Shares?

close

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Welcure Drugs & Pharmaceuticals Ltd shares in BlinkX.

What is the Share Price of Welcure Drugs & Pharmaceuticals Ltd?

close

The share price of any stock is volatile and changes during the day due to a variety of variables. Welcure Drugs & Pharmaceuticals Ltd's share price is ₹0.31 as of 2026-04-21.

What is the PE ratio of Welcure Drugs & Pharmaceuticals Ltd?

close

Welcure Drugs & Pharmaceuticals Ltd's P/E ratio is 1.07 times as of 2026-04-21.

What is the PB ratio of Welcure Drugs & Pharmaceuticals Ltd?

close

Welcure Drugs & Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 0.29, showing the company's stock market valuation in relation to the value of its real assets.

What is the Market Cap of Welcure Drugs & Pharmaceuticals Ltd?

close

Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Welcure Drugs & Pharmaceuticals Ltd's market capitalization is ₹38.31 Cr as on 2026-04-21.

What is the ROE of Welcure Drugs & Pharmaceuticals Ltd?

close

The current financial records of Welcure Drugs & Pharmaceuticals Ltd show a 3.81% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

What is the Total Asset of Welcure Drugs & Pharmaceuticals Ltd?

close

According to Welcure Drugs & Pharmaceuticals Ltd's most recent financial filings, the company has a total asset value of ₹182.14, which includes current and non-current assets such as inventory, cash, properties, and equipment.

What is the 52-week high and Low of Welcure Drugs & Pharmaceuticals Ltd?

close

The 52-week high/low price of a Welcure Drugs & Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Welcure Drugs & Pharmaceuticals Ltd's 52-week high and low as of 2026-04-21 are ₹1.44 and ₹0.23, respectively.